Strain-dependent neurochemical and neuroendocrine effects of desipramine, but not fluoxetine or imipramine, in Spontaneously Hypertensive and Wistar-Kyoto rats

Neuropharmacology

Volumn 39, Issue 12, 2000, Pages 2464-2477

  Durand, Marlène ^a   Aguerre, Sylvie ^a   Fernandez, Francesca ^a   Edno, Leila ^b   Combourieu, Isabelle ^b   Mormède, Pierre ^a   Chaouloff, Francis ^a  

^a INSERM   (France)

^b CENTRE HOSPITALIER CHARLES PERRENS   (France)

Author keywords

ACTH; Desipramine; Fluoxetine; Imipramine; Serotonergic and noradrenergic systems; SHR; WKY rat

Indexed keywords

CORTICOTROPIN; DESIPRAMINE; FLUOXETINE; IMIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; EMOTION; GENETIC ASSOCIATION; MALE; MAZE TEST; MOOD; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN CHEMISTRY; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; MALE; MESENCEPHALON; NEUROSECRETORY SYSTEMS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SPECIES SPECIFICITY;

EID: 0033884271     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00088-5     Document Type: Article

References (74)

1. Andrews N., File S.E. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. European Journal of Pharmacology. 235:1993;109-112.
2. 3H]nisoxetine autoradiography. Brain Research. 582:1992;208-214.
3. Benmansour S., Cecchi M., Morilak D.A., Gerhard G.A., Javors M.A., Gould G.G.et al. Effects of chronic antidepressants treatments on serotonin transporter function, density, and mRNA level. Journal of Neuroscience. 19:1999;10494-10501.
4. Bertilsson L., Dahl M.-L. Polymorphic drug oxidation. Clinical Concepts. 5:1996;200-223.
5. Berton O., Durand M., Aguerre S., Mormède P., Chaouloff F. Behavioral neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain. Neuroscience. 92:1999;327-341.
6. Bouchard T.J. Genes, environment and personality. Science. 264:1994;1700-1701.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein-dye binding. Analytical Biochemistry. 72:1976;248-254.
8. 1A agonists on stress-induced deficit in open field locomotor activity of rats: evidence that this model identifies anxiolytic-like activity. Neuropharmacology. 28:1989;471-476.
9. 2A receptor-mediated head shakes, and behaviours in models of anxiety. Neuropharmacology. 33:1994;449-456.
10. 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology. 35:1996;63-70.
11. Collier D.A., Stöber G., Li T., Heils A., Catalano M., Di Bella D.et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Molecular Psychiatry. 1:1996;453-460.
12. Collier D.A., Arranz M.J., Sham P., Battersby S., Vallada H.P., Gill P.et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. NeuroReport. 7:1996;1675-1679.
13. Conti L.H., Youngblood K.L., Printz M.P., Foote S.L. Locus coeruleus electrophysiological activity and responsivity to corticotropin-releasing factor in inbred hypertensive and normotensive rats. Brain Research. 774:1997;27-34.
14. Durand M., Berton O., Aguerre S., Edno L., Combourieu I., Mormède P.et al. Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis in SHR and WKY rats. Neuropharmacology. 38:1999;893-907.
15. 8 column and ultraviolet detection. Clinical Chemistry. 39:1993;1749-1750.
16. File S.E. The biological basis of anxiety. Meltzer H.Y., Nerozzi D. Current Practices and Future Developments in the Pharmacotherapy of Mental Disorders. 1991;159-165 Elsevier, Amsterdam, The Netherlands.
17. Gentsch C., Lichtsteiner M., Feer H. Open field and elevated plus-maze: a behavioural comparison between spontaneously hypertensive and Wistar-Kyoto rats and the effects of chlordiazepoxide. Behavioral Brain Research. 25:1987;101-107.
18. 4 receptors in rats. Naunyn-Schmiedeberg's Archives in Pharmacology. 356:1997;22-28.
19. Griebel G. Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional response in anxiety models in rodents. Psychopharmacology. 113:1994;463-470.
20. Griebel G., Cohen C., Perrault G., Sanger D.J. Behavioural effects of acute and chronic fluoxetine in Wistar-Kyoto rats. Physiology and Behavior. 67:1999;315-320.
21. Handley S.L., McBlane J.W. 5-HT drugs in animal models of anxiety. Psychopharmacology. 112:1993;13-20.
22. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends in Neurosciences. 20:1997;78-84.
23. Hoffmann O., Plesan A., Wiesenfeld-Hallin Z. Genetic differences in morphine sensitivity, tolerance and withdrawal in rats. Brain Research. 806:1998;232-237.
24. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Reviews. 17:1996;187-205.
25. 2 receptors in rat brain: an autoradiographic study. Synapse. 14:1993;324-331.
26. 3 receptor subtypes. British Journal of Pharmacology. 114:1995;391P.
27. Johnson A.M. The comparative pharmacological properties of selective reuptake inhibitors in animals. Feighner J.P., Boyer W.F. Selective Serotonin Reuptake Inhibitors. Perspectives in Psychiatry. 1:1991;37-47 John Wiley & Sons, New York, USA.
28. Kennett G.A., Chaouloff F., Marcou M., Curzon G. Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin. Brain Research. 382:1986;416-421.
29. 1A agonists and conventional antidepressants in an animal model of depression. European Journal of Pharmacology. 134:1987;265-274.
30. Kiel J.S., Abramson R.K., Morgan S.L., Voris L.C. A rapid high performance liquid chromatography method for the simultaneous measurement of six tricyclic antidepressants. Journal of Liquid Chromatography. 6:1983;2761-2773.
31. Kulikov A., Aguerre S., Berton O., Ramos A., Mormède P., Chaouloff F. Central serotonergic systems in the spontaneously hypertensive and Lewis rat strains that differ in the elevated plus-maze test of anxiety. Journal of Pharmacology and Experimental Therapeutics. 281:1997;775-784.
32. Lahmame A., Armario A. Differential responsiveness of inbred strains of rats to antidepressants in the forced swimming test: are Wistar Kyoto rats an animal model of subsensitivity to antidepressants? Psychopharmacology. 123:1996;191-198.
33. Lahmame A., del Arco C., Pazos A., Yritia M., Armario A. Are Wistar Kyoto rats a genetic model of depression resistant to antidepressants? European Journal of Pharmacology. 337:1997;115-123.
34. Lesch K.P., Aulakh C.S., Wolozin B.L., Tolliver T.J., Hill J.L., Murphy D.L. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Molecular Brain Research. 17:1993;31-35.
35. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S.et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
36. 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biological Psychiatry. 43:1998;547-573.
37. Lopez-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology. 22:2000;191-199.
38. Low W.C., Whitehorn D., Hendley E. Genetically related rats with differences in hippocampal uptake of norepinephrine and maze performance. Brain Research Bulletin. 12:1984;703-709.
39. Luscombe, G.P., Mazurkiewicz, S.E., Buckett, W.R., 1990. Evaluation of tricyclic antidepressants in the elevated plus-maze in rats: anxiolytic effect of diothiepin and doxepin. British Journal of Pharmacology 100 (Suppl.): 356P.
40. Maggi A., U'Prichard D.C., Enna S.J. Differential effects of antidepressant treatment on brain monoaminergic receptors. European Journal of Pharmacology. 61:1980;91-98.
41. May D.G. Genetic differences in drug disposition. Journal of Clinical Pharmacology. 31:1994;881-897.
42. McCarty R. Stress, behavior and experimental hypertension. Neuroscience and Biobehavioral Reviews. 7:1983;493-502.
43. Miyawaki T., Kawamura H., Mitsubayashi H., Usui W., Yasugi T. Altered basal firing pattern and postactivation inhibition of locus coeruleus neurons in spontaneously hypertensive rats. Neuroscience Letters. 137:1992;37-40.
44. Moisan M.P., Courvoisier H., Bihoreau M.T., Gauguier D., Hendley E.D., Lathrop M.et al. A major quantitative trait locus influences hyperactivity in WKHA rat. Nature Genetics. 14:1996;471-473.
45. Mongeau R., Blier P., de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Research Reviews. 23:1997;145-195.
46. Newman M.E., Drummer D., Lerer B. Single and combined effects of desipramine and lithium on serotonergic receptor number and second messenger function in rat brain. Journal of Pharmacology and Experimental Therapeutics. 252:1990;826-831.
47. 1A-mediated inhibition of forskolin-stimulated adenylate cyclase activity in the hippocampal membranes from rats chronically treated with lithium or antidepressants. Journal of Neural Transmission. 86:1991;85-96.
48. Palmer A.A., Printz M.P. Strain differences in Fos expression following airpuff startle in spontaneously hypertensive and Wistar Kyoto rats. Neuroscience. 89:1999;965-978.
49. Paré W.P. Stress ulcer susceptibility and depression in Wistar Kyoto (WKY) rats. Physiology and Behavior. 46:1989;993-998.
50. Paré W.P., Tejani-Butt S.M. Effect of stress on the behavior and 5-HT system in Sprague-Dawley and Wistar Kyoto rat strains. Integrative Physiological and Behavioral Sciences. 31:1996;112-121.
51. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods. 14:1985;149-167.
52. Peroutka S.J., Snyder S.H. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science. 210:1980;88-90.
53. Piciotto M.R. Knock-out mouse models used to study neurobiological systems. Critical Reviews in Neurobiology. 13:1999;103-149.
54. Pineyro G., Blier P., Dennis P., De Montigny M.C. Desensitization of the neuronal 5-HT carrier following its long-term blockade. Journal of Neuroscience. 14:1994;3036-3047.
55. 3H]imipramine high-affinity binding sites in rat brain. Effects of imipramine and lithium. Psychopharmacology. 77:1982;94-97.
56. Plomin R., Owen M.J., McGuffin P. The genetic basis of complex human behaviors. Science. 264:1994;1733-1739.
57. Pollier F., Sarre S., Aguerre S., Ebinger G., Mormède P., Michotte Y.et al. Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality. Neuropsychopharmacology. 22:2000;64-76.
58. Ramos A., Berton O., Mormède P., Chaouloff F. A multiple test study of anxiety related behaviours in six inbred rat strains. Behavioral Brain Research. 85:1997;57-69.
59. Ramos A., Mellerin Y., Mormède P., Chaouloff F. A genetic and multifactorial analysis of anxiety-related behaviours in Lewis and SHR intercrosses. Behavioral Brain Research. 96:1998;195-205.
60. Ramos A., Moisan M.-P., Chaouloff F., Mormède C., Mormède P. Identification of female-specific QTLs affecting an emotionality-related behavior in rats. Molecular Psychiatry. 4:1999;453-462.
61. Ressler K.J., Nemeroff C.B. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biological Psychiatry. 46:1999;1219-1233.
62. Rudorfer M.V., Potter W.Z. The role of metabolites of antidepressants in the treatment of depression. Drug Therapy. 7:1997;273-312.
63. Sanchez C., Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cellular and Molecular Neurobiology. 19:1999;467-489.
64. Silva M.T.A., Alves C.R.R., Santarem E.M.M. Anxiogenic-like effect of acute and chronic fluoxetine on rats tested on the elevated plus-maze. Brazilian Journal of Medical and Biological Research. 32:1999;333-339.
65. Smeraldi E., Zanardi R., Benedetti F., Di Bella D., Perez J., Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Molecular Psychiatry. 3:1998;508-511.
66. Söderpalm B. The SHR exhibits less "anxiety" but increased sensitivity to the anticonflict effect of clonidine compared to normotensive controls. Pharmacology and Toxicology. 65:1989;381-386.
67. Spurlock G., Buckland P., O'Donovan M., McGuffin P. Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5-HT transporter. Neuropharmacology. 33:1994;433-440.
68. Tadokoro C., Kiuchi Y., Yamazaki Y., Nara K., Oguchi K., Kamijima K. Behavioral stimulation without alteration of β and 5-HT receptors and adenylate cyclase activity in rat brain after chronic sertraline administration. Psychopharmacology. 130:1997;124-130.
69. 3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenerate binding. Journal of Pharmacology and Experimental Therapeutics. 260:1992;427-436.
70. Tejani-Butt S.M., Paré W.P., Yang J. Effect of repeated novel stressors on depressive behavior and brain norepinephrine receptor system in Sprague-Dawley and Wistar Kyoto (WKY) rats. Brain Research. 649:1994;27-35.
71. Tuomisto L., Yamtodani A., Dietl H., Waldmann U., Philippu A. In vivo release of endogenous catecholamines, histamine and GABA in the hypothalamus of Wistar Kyoto and spontaneously hypertensive rats. Naunyn-Schmiedeberg's Archives in Pharmacology. 323:1983;183-187.
72. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Science. 57:1995;411-441.
73. Young E.A., Vazquez D. Hypercortisolemia, hippocampal glucocorticoid receptors, and fast feed back. Molecular Psychiatry. 1:1996;149-159.
74. Zafar H.M., Paré W.P., Tejani-Butt S.M. Effect of acute or repeated stress on behavior and brain norepinephrine system in Wistar-Kyoto (WKY) rats. Brain Research Bulletin. 44:1997;289-295.